Alpine Woods Capital Investors, LLC Evolus, Inc. Transaction History

Alpine Woods Capital Investors, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 May 06, 2019	SELL	$12.43 - $28.91 $153,771 - $357,645	-12,371 Closed	0 $0
Q4 2018 Feb 13, 2019	SELL	$10.57 - $19.29 $9,819 - $17,920	-929 Reduced 6.98%	12,371 $147,000
Q3 2018 Nov 08, 2018	BUY	$17.31 - $29.82 $57,122 - $98,406	3,300 Added 33.0%	13,300 $248,000
Q2 2018 Aug 09, 2018	BUY	$6.85 - $38.49 $68,500 - $384,900	10,000 New	10,000 $280,000

168

47.8M

130K

51K

Ticker EOLS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 56,094,800
Market Cap $609M
Description
Evolus, Inc., a performance beauty company, provides medical aesthetic products for physicians and their patients in the United States. It offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults. The company was incorp...

Get notified when there are updates to the investment portfolio of Alpine Woods Capital Investors, LLC, based on Form 13F filings with the SEC.

Stay updated on Alpine Woods Capital Investors, LLC with notifications on news.